1. Gatalica, Zoran, Xiu, Joanne, Swensen, Jeffrey, Vranic, Semir. 2018. Molecular characterization of cancers with NTRK gene fusions. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 32, 147-153. doi:10.1038/s41379-018-0118-3. https://pubmed.ncbi.nlm.nih.gov/30171197/
2. Mortensen, Lindsey, Ordulu, Zehra, Dagogo-Jack, Ibiayi, Bardia, Aditya, Spring, Laura M. 2021. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. In The oncologist, 26, 818-824. doi:10.1002/onco.13880. https://pubmed.ncbi.nlm.nih.gov/34176200/
3. Solomon, J P, Benayed, R, Hechtman, J F, Ladanyi, M. . Identifying patients with NTRK fusion cancer. In Annals of oncology : official journal of the European Society for Medical Oncology, 30, viii16-viii22. doi:10.1093/annonc/mdz384. https://pubmed.ncbi.nlm.nih.gov/31738428/
4. Cai, Jiaoyang, Huang, Xia, Yin, Minzhi, Li, Yanxin, Shen, Shuhong. 2018. A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis. In International journal of cancer, 144, 117-124. doi:10.1002/ijc.31636. https://pubmed.ncbi.nlm.nih.gov/30098202/
5. Li, H Q, Chen, X Y, Yu, X B, Wu, Z Z, Chen, Zhizong. . [Clinicopathological features of NTRK3 gene rearrangement papillary thyroid carcinoma]. In Zhonghua bing li xue za zhi = Chinese journal of pathology, 51, 126-131. doi:10.3760/cma.j.cn112151-20210826-00606. https://pubmed.ncbi.nlm.nih.gov/35152631/
6. Luo, Yanxin, Kaz, Andrew M, Kanngurn, Samornmas, Markowitz, Sanford D, Grady, William M. 2013. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer. In PLoS genetics, 9, e1003552. doi:10.1371/journal.pgen.1003552. https://pubmed.ncbi.nlm.nih.gov/23874207/
智鼠故事 
